Apixaban and Memory Supplements: Safety Considerations

Introduction to Apixaban Metabolism

Apixaban is primarily metabolized via the liver through cytochrome P450 3A4 (CYP3A4)-dependent pathways, with approximately 27% of total drug clearance occurring via renal elimination, and it is a substrate of P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) transporters 3, 4
The American College of Cardiology recommends considering the metabolic pathways of apixaban when evaluating potential drug interactions with memory supplements 6

Supplements containing St. John's wort are P-glycoprotein inducers that can decrease apixaban levels to subtherapeutic blood levels, reducing anticoagulant effectiveness, according to the American Heart Association 5, 6
Ginkgo biloba, a common memory supplement, has antiplatelet properties that may increase bleeding risk when combined with apixaban, as reported by the National Comprehensive Cancer Network 1
The European Respiratory Society notes that supplements that inhibit CYP3A4 or P-gp could potentially increase apixaban levels, leading to increased bleeding risk 2

The American College of Cardiology recommends avoiding supplements containing St. John's wort as they can significantly reduce apixaban effectiveness through P-gp induction 5, 6
The National Comprehensive Cancer Network advises avoiding supplements with known antiplatelet effects (like ginkgo biloba, high-dose vitamin E, garlic supplements) as they may increase bleeding risk 1
The American Heart Association suggests consulting a healthcare provider before starting any memory supplement to evaluate potential drug interactions 1, 2

Patients with moderate to severe renal impairment (CrCl <30 mL/min) are at higher risk for adverse effects from drug interactions, according to the National Comprehensive Cancer Network and the American Heart Association 1, 5
The American College of Cardiology notes that patients with liver disease should be particularly cautious as apixaban is primarily metabolized via the liver 3, 6
Elderly patients (>75 years) are more susceptible to adverse effects from drug interactions, as reported by the National Comprehensive Cancer Network and the American Heart Association 1, 7

The National Comprehensive Cancer Network recommends monitoring for signs of bleeding if taking any supplement with apixaban (unusual bruising, nosebleeds, bleeding gums, heavier than normal menstrual bleeding) 1
The American Heart Association advises against self-adjusting apixaban dose and stopping apixaban abruptly, as this can increase stroke risk in patients with atrial fibrillation 5